DAAO inhibitors (Eisai)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameDAAO inhibitors (Eisai)
Drug Alias NameDAAO inhibitors (MGI Pharma)D-amino acid oxidase inhibitors (MGI Pharma)CBIO
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionD-amino-acid oxidase inhibitors
TargetsD-amino-acid oxidase
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMgi Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEisai Co LtdMgi Pharma Inc
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A